News About: Goverment
Rules concerning bioequivalence test standards eased
The Korea Food and Drug Administration announced the drastically eased rules concerning bioequivalence test standards and drug equivalence test managements, salient points of which are as follows:
1) Bioequivalence...
Pharmacy unable to get advice fees without supportive data.
The NHI payment for medication advice fees raised by quite a number of pharmacy was rejected on account of no advice evidences on the dispensing records detected during the HIRA's field inspection.
According to Gy...
Korea will ban all human cloning with limited permission
The bioethics law defining the limited scope of embryonic stem cell (ESC) research for human cloning is likely to be legislated.
The Life, Ethics and Safety Measures bill, which hit snag by policy conflicts between...
100 thousand cancer patients newly registered last year.
It was reported that about 100 thousand of new patients were suffering from cancers last year and the total NHI payment for 250 thousand patients including over 140 thousands of old patients amounted to 641,600 millio...
Health ministry pushing to implement new drug plan
Pharmaceutical business sources say that the Ministry of Health and Welfare have yet to fully reflect rational oppositions of pharmaceutical firms raised by the previous public hearings on the new drug price re-evalua...
Informations to share for new drug development
The informations of new drugs on research in Korea seem to be easily accessible.
The KFDA plans to publish a updated Survey Report on New Drug Development (hereinafter called "Survey Report") for the purpose of bo...
Frequently prescribed nutritional amino acid transfusions may be produced by drug makers
Pharmaceutical manufacturers are likely to market the nutritional amino acid transfusions, which are now being produced by mixing amino acid transfusions with some nutritional agents at a hospital drug department itse...
NHI price review for bio equivalent drugs shortened within a month .
The KFDA, in the brief talk meeing with the HIRA on Nov. 8, decided to give additional benefit plans to the 30% incentive program for the pharmacists who substitute prescriptions for other bio equivalent drugs to boos...
Safety information profiles on 84 substances announced
The Korea Food and Drug Administration announced the additional safety information profiles on 84 substances, including cimetidine, cefotaxime, and ranitidine, saying that these side effects should be included in prec...
Medical and pharmaceutical circles and government differ on health insurance treatment
Medical and pharmaceutical circles and government differ on health insurance treatment/dispensing charges
In the November 5 meeting of the Health Insurance Policy Deliberation Committee (HIPDC), the Ministry of Hea...
